Page 150 - 南京医科大学学报自然科学版

第43卷第9期
·1328 · 南 京 医 科 大 学 学 报 2023年9月

Nephrol Dial Transplant，1995，10（Suppl 8）：3-7 from a literature review and two major registries［J］. Uroli⁃
［12］ HOPPE B，BECK B B，MILLINER D S. The primary hyper⁃ thiasis，2018，46（2）：187-195
oxalurias［J］. Kidney Int，2009，75（12）：1264-1271 ［23］ MIZUSAWA Y，PARNHAM A P，FALK M C，et al. Poten⁃
［13］ BOLLÉE G，COCHAT P，DAUDON M. Recurrence of tial for bilateral nephrectomy to reduce oxalate release
crystalline nephropathy after kidney transplantation in after combined liver and kidney transplantation for primary
APRT deficiency and primary hyperoxaluria［J］. Can J hyperoxaluria type 1［J］. Clin Transplant，1997，11（5 Pt
Kidney Health Dis，2015，2：31 1）：361-365
［14］ HARAMBAT J，FARGUE S，ACQUAVIVA C，et al. Geno⁃ ［24］ BRINKERT F，GANSCHOW R，HELMKE K，et al. Trans⁃
type⁃phenotype correlation in primary hyperoxaluria type plantation procedures in children with primary hyperoxal⁃
1：the p.Gly170Arg AGXT mutation is associated with a uria type 1：outcome and longitudinal growth［J］. Trans⁃
better outcome［J］. Kidney Int，2010，77（5）：443-449 plantation，2009，87（9）：1415-1421
［15］ COCHAT P，HULTON S A，ACQUAVIVA C，et al. Primary ［25］ ADAM R，KARAM V，CAILLIEZ V，et al. 2018 Annual
hyperoxaluria type 1：indications for screening and guid⁃ report of the european liver transplant registry（ELTR）⁃ 50
ance for diagnosis and treatment［J］. Nephrol Dial Trans⁃ ⁃ year evolution of liver transplantation［J］. Transpl Int，
plant，2012，27（5）：1729-1736 2018，31（12）：1293-1317
［16］ MONICO C G，ROSSETTI S，OLSON J B，et al. Pyridoxine ［26］ DEVRESSE A，COCHAT P，GODEFROID N，et al. Trans⁃
effect in type I primary hyperoxaluria is associated with plantation for primary hyperoxaluria type 1：designing
the most common mutant allele［J］. Kidney Int，2005，67 new strategies in the era of promising therapeutic perspec⁃
（5）：1704-1709 tives［J］. Kidney Int Rep，2020，5（12）：2136-2145
［17］ DÍAZ C，CATALINAS F G，DE ALVARO F，et al. Long ［27］ GARRELFS S F，FRISHBERG Y，HULTON S A，et al.
daily hemodialysis sessions correct systemic complica⁃ Lumasiran，an RNAi therapeutic for primary hyperoxal⁃
tions of oxalosis prior to combined liver⁃kidney transplan⁃ uria type 1［J］. N Engl J Med，2021，384（13）：1216-1226
tation：case report［J］. Ther Apher Dial，2004，8（1）：52-55 ［28］ SAS D J，MAGEN D，HAYES W，et al. Phase 3 trial of
［18］ PLUMB T J，SWEE M L，FILLAUS J A. Nocturnal home lumasiran for primary hyperoxaluria type 1：a new RNAi
hemodialysis for a patient with type 1 hyperoxaluria［J］. therapeutic in infants and young children［J］. Genet Med，
Am J Kidney Dis，2013，62（6）：1155-1159 2022，24（3）：654-662
［19］ ELLIS S R，HULTON S A，MCKIERNAN P J，et al. Com⁃ ［29］ ARICETA G，BARRIOS K，BROWN B D，et al. Hepatic
bined liver⁃kidney transplantation for primary hyperoxal⁃ lactate dehydrogenase A：an RNA interference target for
uria type 1 in young children［J］. Nephrol Dial Trans⁃ the treatment of all known types of primary hyperoxaluria
plant，2001，16（2）：348-354 ［J］. Kidney Int Rep，2021，6（4）：1088-1098
［20］ KEMPER M J. Concurrent or sequential liver and kidney ［30］ LE DUDAL M，HUGUET L，PEREZ J，et al. Stiripentol
transplantation in children with primary hyperoxaluria protects against calcium oxalate nephrolithiasis and ethyl⁃
type 1?［J］. Pediatr Transplant，2005，9（6）：693-696 ene glycol poisoning［J］. J Clin Invest，2019，129（6）：
［21］ ALKHUNAIZI A M，AL⁃SANNAA N A，RASLAN W F. 2571-2577
Hyperoxaluria and rapid development of renal failure ［31］ METRY E L，VAN DIJK L，PETERS⁃SENGERS H，et al.
following a combined liver and kidney transplantation： Transplantation outcomes in patients with primary hyper⁃
emphasis on sequential transplantation［J］. JIMD Rep， oxaluria：a systematic review［J］. Pediatr Nephrol，2021，
2012，3：91-95 36（8）：2217-2226
［22］ TALATI J J，HULTON S A，GARRELFS S F，et al. Primary ［收稿日期］ 2023-02-07
hyperoxaluria in populations of Pakistan origin：results （本文编辑：陈汐敏）